scanX
Home
Morepen Laboratories

Morepen Laboratories

61.23
-1.45
(-2.31%)
Market Cap
3,355.10
EPS
1.88
PE Ratio (TTM)
26.63
Dividend Yield
0.00
Industry
Healthcare
52 Week High
100.90
52 Week low
38.55
PB Ratio
3.02
Debt to Equity
0.03
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
Morepen Laboratories Reports Decline in Q3 EBITDA and Margin3 days ago
Morepen Laboratories experienced a significant decrease in its third-quarter financial performance. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) fell to 361 million rupees from 506 million rupees in the same quarter of the previous year. Additionally, the EBITDA margin dropped to 7.98% from 11.37% year-over-year, indicating a substantial reduction in profitability.
neutral
Morepen Laboratories Reports Q3 Revenue Growth3 days ago
Morepen Laboratories has announced its financial results for the third quarter. The company reported revenue of 4.5 billion rupees, compared to 4.44 billion rupees in the same period last year, indicating a slight year-over-year increase.
negative
Morepen Laboratories Reports Q3 Net Profit Decline3 days ago
Morepen Laboratories announced its Q3 consolidated net profit of 267 million rupees, down from 320 million rupees in the same period last year, representing a year-over-year decrease.
Growth Rate
Revenue Growth
19.72 %
Net Income Growth
149.61 %
Cash Flow Change
180.48 %
ROE
121.79 %
ROCE
113.54 %
EBITDA Margin (Avg.)
68.27 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
402
486
599
610
772
863
1,200
1,557
1,424
1,704
1,787
Expenses
352
424
534
542
701
785
1,070
1,410
1,338
1,532
1,589
EBITDA
50
63
65
69
71
78
131
147
86
173
198
Operating Profit %
12 %
13 %
10 %
11 %
9 %
8 %
10 %
9 %
6 %
9 %
10 %
Depreciation
39
35
34
34
40
37
30
28
28
34
22
Interest
9
11
8
4
2
2
2
-7
2
4
4
Profit Before Tax
2
13
24
30
29
39
99
127
56
135
172
Tax
0
-0
0
0
0
6
1
25
17
39
45
Net Profit
2
13
24
30
29
34
97
102
39
97
126
EPS in ₹
0.04
0.28
0.53
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.40
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
489
524
538
586
615
664
858
1,070
1,111
1,293
Fixed Assets
323
297
272
264
236
216
225
252
267
307
Current Assets
115
157
192
243
300
372
527
734
756
889
Capital Work in Progress
0
0
0
0
0
0
2
14
17
25
Investments
0
0
0
0
0
1
1
0
0
1
Other Assets
167
227
267
321
379
446
631
804
827
960
Total Liabilities
489
524
538
586
615
664
858
1,070
1,111
1,293
Current Liabilities
128
167
325
340
339
351
404
457
321
402
Non Current Liabilities
74
58
18
20
23
28
30
36
37
44
Total Equity
287
300
196
226
253
284
424
578
752
847
Reserve & Surplus
78
91
106
136
163
194
291
457
651
745
Share Capital
210
210
90
90
90
90
90
96
102
102
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-5
3
-1
4
4
28
-26
6
-5
Investing Activities
-32
-27
-14
-27
-13
-13
-70
-32
-47
-83
Operating Activities
51
50
41
63
17
11
51
-60
-91
73
Financing Activities
-19
-27
-24
-38
-0
6
47
66
144
5
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Promoter
34.54 %
34.54 %
34.54 %
34.54 %
38.38 %
36.74 %
36.74 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
35.65 %
35.65 %
35.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.29 %
0.00 %
1.85 %
1.67 %
7.72 %
2.08 %
2.22 %
DIIs
2.89 %
2.03 %
1.26 %
1.16 %
1.07 %
4.07 %
4.07 %
3.60 %
3.74 %
2.93 %
2.33 %
2.28 %
2.00 %
2.15 %
2.15 %
2.90 %
1.70 %
1.64 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
42.97 %
43.89 %
44.82 %
45.18 %
42.50 %
40.88 %
40.91 %
43.63 %
44.03 %
45.04 %
45.49 %
45.56 %
44.44 %
45.03 %
45.22 %
41.89 %
48.16 %
48.35 %
No of Share Holders
1,65,609
2,30,611
2,44,924
2,55,155
2,60,933
2,83,547
2,87,115
2,87,370
3,06,030
3,06,150
3,01,832
3,04,001
3,04,289
3,36,019
3,48,766
3,52,839
4,30,929
4,48,361

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
2 days ago
Integrated Filing (Financial)
2 days ago
View more

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,749.80 4,19,835.60 35.59 49,887.20 12.06 9,648 13.77 44.72
Divis Laboratories
6,140.55 1,63,012.30 78.87 8,184.00 0.89 1,600 64.53 60.55
Cipla
1,472.25 1,18,901.00 23.83 26,520.70 14.17 4,155 47.38 53.79
Torrent Pharmaceuticals
3,258.60 1,10,285.80 59.24 10,785.70 11.59 1,656 13.54 50.87
Mankind Pharma
2,518.60 1,03,909.10 50.90 10,615.60 19.57 1,942 -16.38 45.50
Dr Reddys Laboratories
1,240.40 1,03,500.30 19.27 28,905.40 12.36 5,578 1.69 45.18
Lupin
2,201.15 1,00,415.90 38.23 20,141.50 19.94 1,936 73.53 57.74
Zydus Life Science
994.15 1,00,034.80 22.06 19,831.50 13.82 3,831 29.92 55.02
Aurobindo Pharma
1,191.70 69,214.10 19.63 29,559.20 17.55 3,169 -10.04 48.98
Abbott
29,799.60 63,322.10 47.45 6,097.20 10.80 1,201 16.01 66.61

Corporate Action

Technical Indicators

RSI(14)
Neutral
38.68
ATR(14)
Less Volatile
3.15
STOCH(9,6)
Neutral
57.91
STOCH RSI(14)
Neutral
73.68
MACD(12,26)
Bullish
0.39
ADX(14)
Strong Trend
35.80
UO(9)
Bearish
45.04
ROC(12)
Downtrend And Accelerating
-7.33
WillR(14)
Neutral
-63.25
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Candlestick Screeners
Technical Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.